About Qpex Biopharma
Qpex Biopharma is a company based in San Diego (United States) founded in 2018 was acquired by Shionogi in June 2023.. Qpex Biopharma has raised $33 million across 1 funding round from investors including Shionogi, NEA and Adams Street Partners. The company has 12 employees as of December 31, 2022. Qpex Biopharma offers products and services including Antibiotics Development and Enzyme Inhibition Therapies. Qpex Biopharma operates in a competitive market with competitors including Spero Therapeutics, Nabriva, Melinta Therapeutics, Iterum Therapeutics and Adaptive Phage Therapeutics, among others.
- Headquarter San Diego, United States
- Employees 12 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Qpex Biopharma, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Qpex Biopharma
Qpex Biopharma offers a comprehensive portfolio of products and services, including Antibiotics Development and Enzyme Inhibition Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Creates new antibiotics to target drug-resistant pathogens effectively.
Develops therapies to inhibit enzymes and restore antibiotic potency.
Unlock access to complete
Leadership Team
4 people
Finance and Accounting
1 people
Operations Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Qpex Biopharma
Qpex Biopharma has successfully raised a total of $33M through 1 strategic funding round. The most recent funding activity was a Series A round of $33 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $33.0M
-
First Round
First Round
(31 Jul 2019)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2019 | Amount | Series A - Qpex Biopharma | Valuation | New Enterprise Associates |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Qpex Biopharma
Qpex Biopharma has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Shionogi, NEA and Adams Street Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Private markets investment management with strategies in equity, credit, and secondary investments.
|
Founded Year | Domain | Location | |
|
A global healthcare-focused VC/PE firm is operated.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Qpex Biopharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Qpex Biopharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Qpex Biopharma Comparisons
Competitors of Qpex Biopharma
Qpex Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Spero Therapeutics, Nabriva, Melinta Therapeutics, Iterum Therapeutics and Adaptive Phage Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for drug-resistant bacterial infections are developed.
|
|
| domain | founded_year | HQ Location |
Pleuromutilin antibiotics are developed for MDR infections.
|
|
| domain | founded_year | HQ Location |
Developer of bacterial ribosome-targeting drugs for MDR infections
|
|
| domain | founded_year | HQ Location |
Developer of antibiotics for MDR infections
|
|
| domain | founded_year | HQ Location |
Therapies for multi-drug resistant infections are developed using bacteriophages.
|
|
| domain | founded_year | HQ Location |
Therapeutics for antimicrobial resistant infections are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Qpex Biopharma
Frequently Asked Questions about Qpex Biopharma
When was Qpex Biopharma founded?
Qpex Biopharma was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is Qpex Biopharma located?
Qpex Biopharma is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Qpex Biopharma?
Michael Dudley is the current CEO of Qpex Biopharma.
Is Qpex Biopharma a funded company?
Qpex Biopharma is a funded company, having raised a total of $33M across 1 funding round to date. The company's 1st funding round was a Series A of $33M, raised on Jul 31, 2019.
How many employees does Qpex Biopharma have?
As of Dec 31, 2022, the latest employee count at Qpex Biopharma is 12.
What does Qpex Biopharma do?
Qpex Biopharma was founded in 2018 and is based in San Diego, United States. Operations focus on the biopharma sector, where therapies for infectious diseases are advanced. Proprietary beta-lactamase inhibitor technology is employed to develop antibiotics that address drug-resistant and gram-negative infections. Undisclosed anti-infective candidates are being progressed through this platform to tackle unmet needs in antimicrobial treatment.
Who are the top competitors of Qpex Biopharma?
Qpex Biopharma's top competitors include Spero Therapeutics, Melinta Therapeutics and Vedanta Biosciences.
What products or services does Qpex Biopharma offer?
Qpex Biopharma offers Antibiotics Development and Enzyme Inhibition Therapies.
Who are Qpex Biopharma's investors?
Qpex Biopharma has 5 investors. Key investors include Shionogi, NEA, Adams Street Partners, LYZZ Capital, and Hatteras Venture Partners.